Please login to the form below

Not currently logged in
Email:
Password:

Recordati

This page shows the latest Recordati news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Sanofi’s all-oral sleeping sickness drug

CHMP backs Sanofi’s all-oral sleeping sickness drug

Italy’s Recordati also got a positive opinion for Silodosin Recordati (siloosin) a generic of its own Urorec drug used to treat benign prostatic hyperplasia (BPH).

Latest news

More from news
Approximately 3 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    AstraZeneca, Takeda, Astellas Pharma, Novo Nordisk and Recordati take up the final five positions, though only two - Takeda (3.9%) and Astellas (9.3%) - recorded growth.

  • Deal Watch July 2016 Deal Watch July 2016

    BioD. $21.3 plus $56.5 contingent. $22m. 3.5x. N/A. Recordati. Pro Farma. ... Recordati has been busy on the acquisition front recently; in May the company acquired Italichimici for $145m, strengthening its gastroenterology and respiratory ranges, and

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    4. ). 63. Apricus Biosciences (formerly NexMed) / Recordati. Licence. Vitaros topical treatment for erectile dysfunction.

  • Deal Watch table for September 2013 Deal Watch table for September 2013

    246. Laboratorios Casen Fleet/ Recordati. Acquisition. Spanish pharmaceutical company. 123. Pacific Biosciences of California/Roche Diagnostics.

  • Deal Watch table for July 2013 Deal Watch table for July 2013

    50. Opalia Pharma / Recordati .  Acquisition of 90% stake. Branded generic drugs - dermatology, GI, respiratory.

More from intelligence
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Recordati promotes Andrea Recordati to COO Recordati promotes Andrea Recordati to COO

    Milan-based pharmaceutical company Recordati has promoted Andrea Recordati (pictured right) to chief operating officer. ... In his newly-created position, Andrea Recordati will be responsible for all the group's commercial and production activities.

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics